Non-compliance with typical neuroleptic drugs is well established as a major factor in relapse and re-hospitalization of persons with schizophrenia. Non-compliance has typically been attributed to significant extrapyramidal side effects and lack of efficacy. Atypical antipsychotic drugs are expected to have some impact on non-compliance because of generally lower extrapyramidal side effects and better efficacy. Non-compliance with typical antipsychotics is well established, but no information is available on non-compliance with atypicals. While atypical antipsychotic agents are expected to have an impact on compliance, there will likely remain a need for additional compliance-inducing strategies, as depot administrations and attempts to change attitudes toward medications have not proven effective in the long-term. The purpose of this exploratory study is to collect data on compliance with new antipsychotic medications and to test the effectiveness of telephone medication management (TMM) on compliance with a population of persons with schizophrenia and schizoaffective disorders.
The specific aims of this study are: 1) Examine whether compliance with atypical antipsychotic drugs will be better than that with typical neuroleptics; 2) Evaluate the hypothesis that patients in the TMM program will experience superior quality of life, enhanced functioning, and decreased symptoms; 3) Study whether patients in the TMM program will adhere more closely to medication regimens; and 4) Examine the impact of TMM on hospitalization rates. This exploratory study will utilize a randomized 2X2 design involving 96 persons diagnosed with schizophrenia. Research participants will be non-randomized to medication and randomized to the TMM condition or """"""""treatment as usual."""""""" Those assigned to the TMM condition will initially meet with a TMM staffperson and discuss medication attitudes, develop strageies for taking medications on a consistent basis, and provide psychoeducation about medication side effects. The TMM staffperson will then follow this up with weekly telephone contacts in which they will inquire about compliance and conduct a brief clinical interview. The TMM staffperson will initiate appropriate interventions (i.e., schedule an appointment with the persons physician) to combat relapse and emerging side effects.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Small Research Grants (R03)
Project #
1R03MH060161-01
Application #
2883494
Study Section
Special Emphasis Panel (SRCM)
Program Officer
Hsiao, John
Project Start
1999-07-01
Project End
2000-06-30
Budget Start
1999-07-01
Budget End
2000-06-30
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Psychiatry
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Salzer, Mark S; Tunner, Timothy; Charney, Natalie J (2004) A low-cost, telephone intervention to enhance schizophrenia treatment: a demonstration study. Schizophr Res 66:75-6